By: Sheryl Stevenson
Deborah A. Ferrington, PhD, highlights how breakthroughs in imaging, AI, and stem cell research are reshaping ophthalmology.
As part of Ophthalmology Times’ 50th anniversary celebration, leaders in the field are reflecting on the transformative role of science and research in advancing eye care. Deborah A. Ferrington, PhD—chief scientific officer and the Stephen J. Ryan–Arnold and Mabel Beckman Foundation Endowed Presidential Chair at Doheny Eye Institute in Pasadena, California, and a professor in residence at David Geffen School of Medicine at UCLA in Los Angeles, California—points to the significance of advances in imaging technologies, artificial intelligence (AI), and stem cell research as milestones that have redefined diagnosis, treatment, and discovery in ophthalmology.